A rapid ultra-performance LC-MS/MS assay for determination of serum unbound fraction of voriconazole in cancer patients

This assay is suitable for monitoring both unbound and bound VOR in cancer patients especially in those with hypoalbuminemia in clinical laboratories. Measurement of unbound VOR offers a better approach in prediction of VOR toxicity.